The European Federation for Medicinal Chemistry (EFMC) is an independent association representing medicinal chemistry societies in Europe. Its objective is to advance the science of medicinal chemistry by promoting cooperation and networking, by providing training and mentoring, by rewarding scientific excellence, and by facilitating communication and influencing stakeholders.

Meetings  July 2018 Next

The UCB-Ehrlich Award for Excellence in Medicinal Chemistry

The “UCB-Ehrlich Award for Excellence in Medicinal Chemistry” was established to acknowledge and recognize outstanding research in the field of Medicinal Chemistry in its broadest sense. The Award is given biennially, without restrictions regarding nationality, and consists of diploma, € 7.500 and an invitation to present a lecture at an EFMC-ISMC symposium. 

Previous recipients were: Dr. B. Riedl in 2006, Prof. J. Wengel in 2004 and Dr. J. Zimmermann in 2002.


Laureate 2006

Dr Bernd Riedl, Director at BayerHealthCare AG, Leverkusen, Germany
Winner of the 2006 UCB Award for Excellence in Medicinal Chemistry

Dr. Riedl receives this award for his outstanding scientific work leading to the discovery of the raf-kinase inhibitor Sorafenib (Bay-43-9006, Nexavar), the first example of the discovery of a new medicine which combines classical rationale drug discovery approach with the use of new technologies.


Laureate 2004

The UCB Award for Excellence in Medicinal Chemistry 2004 for Prof. Jesper Wengel

The award was granted to Prof. Jesper Wengel, University of Southern Denmark, on the basis of his outstanding scientific curriculum vitae. In particular, his discovery of Locked Nucleic Acids (LNA) has been highly significant in the field of the discovery of effective antisense oligonucleotides. This discovery has greatly enhanced the chances of a successful development of oligonucleotide-based therapeutic agents.

The Award was presented during the Opening Session of the XVIIIth International Symposium on Medicinal Chemistry, on Sunday, August 15, in Copenhagen, Denmark.


Laureate 2002

The UCB Award for Excellence in Medicinal Chemistry 2002 for Dr. Jürg Zimmermann, NOVARTIS, Basel, Switzerland

The first "UCB Award for Excellence in Medicinal Chemistry" has been given to Dr. Jürg Zimmermann of Novartis, Switzerland. Dr. Zimmermann received the Award for his fundamental contributions in medicinal chemistry to the discovery and development of Imatinib (Glivec/Gleevec, STI 571), a Protein Kinase Inhibitor and novel treatment for Chronic Myeloid Leukemia. Imatinib is considered as one of the revolutions in the therapeutic treatment of cancer, and could become the therapy of choice. The Jury noted the Excellence in Medicinal Chemistry, combining chemical knowledge with a profound expertise in molecular pharmacology together with rigorous molecular design techniques, which formed the basis of this work.


M T W T F S S
25 26 27 28 29 30 01
02 03 04 05 06 07 08
09 10 11 12 13 14 15
16 17 18 19 20 21 22
23 24 25 26 27 28 29
30 31 01 02 03 04 05
All events   |  Future events

Job portal

27/04/2018
MsC student or PhD internship, KU Leuven: Cellular and Molecular Medicine, Leuven, Belgium
read more


20/04/2017
Medicinal / Synthetic Organic Chemists, Concept Life Sciences: Drug Discovery, Sandwich, Kent, United Kingdom
read more


Job portal page

Follow us on Facebook

Follow us on Twitter

Follow us on LinkedIn

Follow us on Instagram

ChemBridgeBoehringer IngelheimNovartisProf Dr W. Th. Nauta FoundationPfizerServierRoche
 Prous Institute for Biomedical ResearchUCBJanssen R&DBayerMerck